Collegium Submits New Drug Submission to Health Canada for Xtampza® ER, an Analgesic with Abuse-Deterrent Properties for the Treatment of Chronic Pain
Stock Nod: Quotes,
CANTON, Mass., Oct. 03, 2016 (GLOBE NEWSWIRE) --. (Nasdaq:COLL) announced today the submission of a New Drug Submission (NDS…